Bronwyn Thompson on Muck Rack

Bronwyn Thompson

Sydney
As seen in: Wiley, Wiley Online Library, Stuff.co.nz, Sydney Morning Herald, Biomed Central (BMC), Flipboard, The Age, Constant Contact, New Atlas, The Canberra Times and
former journalist, zoologist in training
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bronwyn

Contact Bronwyn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The largest magnetic map of the Universe captures what we can't see

|
By Bronwyn Thompson
| refractor.io
We're a step closer to understanding how energy is spread across the Universe, with the most detailed map of intergalactic magnetism ever produced. It's more than five times larger than all earlier studies combined. Researchers from Australia’s national science agency CSIRO and the SKA Observatory (SKAO) have produced the detailed images using the ASKAP radio telescope.
Open in Who Shared Issue with article?

New sesame-seed-sized animal found living its best life off Taiwan coast

|
By Bronwyn Thompson
| refractor.io
For nearly 200 years, biologists felt they had a pretty good grasp of the nudibranch genus Thecacera. Consisting of six known species found in marine habitats around the world, these shell-less molluscs seemed as small as small could be, ranging from around half an inch to an inch long. Then, scientists in Taiwan found a seventh species, one barely the size of a grain of rice.
Open in Who Shared Issue with article?

FDA approves pill that cuts COVID risk nearly 70%

|
By Bronwyn Thompson
| refractor.io
The US has its first and only oral COVID-19 post-exposure prophylaxis (PEP) on its way, after a Phase III trial of the drug ensitrelvir met goals required for approval by the US Food and Drug Administration (FDA). Ensitrelvir, which will be sold under the brand name Xocova in the US, was developed by Japanese pharmaceutical company Shionogi. It's been approved for use in Japan since 2024.
Open in Who Shared Issue with article?
See all 1,053 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Bronwyn

Contact Bronwyn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified